(This May 28 story has been corrected to say ‘eye drop,’ not ‘liquid medication,’ in paragraph 3 and to remove the picture) Reuters Health Information
Category: News
Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease
GENEVA–(BUSINESS WIRE)–Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease
Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease
GENEVA–(BUSINESS WIRE)–Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease
Can You Eat Away the Risk for Blindness?
Although cures for age-related macular degeneration are elusive, the case for prevention through nutrition looks strong and certainly better than a shot in the eye. Medscape Medical News
Intranasal Schirmer Test Shows Promise in Allergy Diagnosis
Objective measurement of nasal secretions may help clinicians diagnose allergic rhinitis. Medscape Medical News
Updated McDonald Criteria for MS Allow Earlier Dx and Tx
Drs Andrew Wilner and Oliver Tobin discuss key features of the updated McDonald criteria and how they change the diagnosis of multiple sclerosis. Medscape Neurology
FDA Approves Genentech’s Susvimo for Diabetic Retinopathy
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment…
Hidden Methods, High Stakes: Clinicians Push FDA on NarxCare
A band of clinicians and chronic pain advocates are pushing regulators to scrutinize a controversial risk rating tool. Medscape Medical News
Hidden Formula, High Stakes: Clinicians Push FDA on NarxCare
A band of clinicians and chronic pain advocates are pushing regulators to scrutinize a controversial risk rating tool. Medscape Medical News
Going to Mars? Your Body Might Disagree
Astronauts face severe health risks on their journey to Mars, dealing with muscle loss, vision changes, and immune system challenges. Medscape Medical News
Europa Eyewear Appoints Megan Molony as Chief Executive Officer
CHICAGO–(BUSINESS WIRE)–Europa, a leading designer and manufacturer of premium independent eyewear, proudly announces the appointment of Megan Molony as its new chief executive officer, effective June 16. Molony will oversee the full Europa platform,…
Alfred E. Mann Charities Gives $12 Million for Cell and Gene Therapy Research at Children’s Hospital Los Angeles
LOS ANGELES–(BUSINESS WIRE)–Alfred E. Mann Charities has made a generous gift of $12 million to establish the Alfred E. Mann Cell and Gene Therapy Research Endowment and the Alfred E. Mann Cell and Gene Therapy Research Fund at Children’s Hospital Lo…
Warby Parker Partners with Google To Develop Intelligent Eyewear
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced a partnership with Google to develop AI-powered glasses intended for all-day wear. The partnershi…
Study: Dropless Cataract Surgery Slashes Drug Costs
Injection of an antibiotic and glucocorticoid after cataract surgery is far cheaper and as safe as a protocol 12 drops daily tapered over 4 weeks, a new study shows. Medscape Medical News
Office-Based Cataract Surgery Measures Up To ASC Cases
A retrospective review of 1300 cataract operations by one surgeon finds office-based surgeries are no less safe than ambulatory surgery center cases. Medscape Medical News
Viridian Therapeutics Announces Positive Long-Term Durability Data from the Veligrotug Phase 3 THRIVE Clinical Trial in Patients with Active Thyroid Eye Disease (TED)
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced positive l…
STAAR Surgical Announces $30 Million Share Repurchase Authorization
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that its Board of Directors has authoriz…
National Vision Announces Settlement of 2025 Convertible Senior Notes
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today announced the settlement of the remaining $84.8 million aggregate principal amount of 2.5% unsecured convertible senior notes due May …
Safe Driving Possible Despite Loss of Visual Field
People who experience a reduced visual field as a result of glaucoma or stroke can drive as safely as those of the same age with normal vision, a recent study finds. Medscape Medical News
Alcon Reports First-Quarter 2025 Results and Launches Transformational Change in Ophthalmic Surgery with Unity VCS
GENEVA–(BUSINESS WIRE)–Alcon Reports First-Quarter 2025 Results and Launches Transformational Change in Ophthalmic Surgery with Unity VCS